What is ESPR's dilution risk score?

ESPR currently has a DilutionScore of 48/100, indicating medium dilution risk. DilutionWatch monitors ESPR SEC filings in real-time, scanning EDGAR every 60 seconds for shelf registrations, ATM offerings, warrant exercises, PIPE deals, and reverse split signals.

What SEC filings does DilutionWatch track for ESPR?

DilutionWatch tracks 25 SEC filing types for ESPR including S-3 shelf registrations, 424B prospectuses (ATM offerings), S-1 registration statements, 8-K material events, warrant exercise notices, convertible note agreements, and Form 4 insider transactions. Alerts are delivered via email within minutes of a filing appearing on EDGAR.

How does stock dilution affect ESPR shareholders?

Stock dilution occurs when a company issues new shares, reducing the ownership percentage of existing shareholders. For ESPR, common dilution events include at-the-market (ATM) stock offerings, shelf registration drawdowns, warrant exercises, and convertible note conversions. Each event increases the share count and can pressure the stock price lower.

Is DilutionWatch free for ESPR tracking?

DilutionWatch provides a free tier that shows DilutionScores and basic filing history for ESPR. Premium plans ($19.95/month Basic, $39.95/month Premium) unlock real-time email alerts, the full Pulse™ feed, advanced dilution forecasts, and access to all 10,000+ tracked tickers.

ESPR Dilution Risk Score: 48/100 (MEDIUM)

📊 Score Breakdown

📋 Offering Ability

72

💰 Cash Runway

0

📊 Float Risk

12

⚠️ Warrant Exposure

50

🔄Convertible Debt—

🌦️ Dilution Forecast

☀️

Clear

No significant dilution signals

15%

🔄 Reverse Split 15%

• 52-week low $0.85 has breached $1

📜 Warrant Exercise 15%

• Warrant overhang: 14.4% of shares outstanding

🔁 Convertible Conversion 15%

• Convertible debt present: 12.1% potential dilution

🔔 Track ESPR — Get forecast alerts →

💹 Market Data

Market Cap$805.76M

Shares Outstanding257.43M

Float255.18M

Cash$156.16M

Debt$292.0K

Short InterestN/A

🏛 Institutional Holdings

QoQ: ↑ 29.7% shares (2026Q1 vs prior)

208 institutional holders · 203.70M shares

#1 VANGUARD CAPITAL MANAGEMENT LLC 20.87M shares

#2 BlackRock, Inc. 17.85M shares

#3 WASATCH ADVISORS LP 15.77M shares

+ 17 more holders Sign up free to view →

📉 Short Interest

Short Interest17.40M

Days to Cover1.7

% of Float6.8%

FINRA data as of Jun 30, 2026

👤 Insider Buy/Sell Ratio

📁 Recent SEC Activity

xbrl XBRL CONVERTIBLE Mar 31, 2026

xbrl XBRL WARRANT Dec 31, 2025

8-K 8K EVENT Apr 02, 2026

4 INSIDER TRANSACTION Mar 18, 2026

Full SEC filing analysis available with free account →

📰 Recent News

No recent news

📋 What This Means for ESPR Shareholders

Esperion Therapeutics, Inc. (ESPR) has a DilutionScore of 48/100, rated Medium dilution risk. This tier indicates some dilution exposure — often an older shelf registration with remaining capacity, warrants not yet exercised, or a cash position that will require monitoring over the next several quarters. Score as of July 14, 2026.

DilutionWatch tracks 37.0M outstanding warrants for ESPR. Warrants become dilutive when exercised — converting to common shares at the strike price. Warrants near or in-the-money deserve particular attention since exercise can add materially to the outstanding share count within a short window.

DilutionWatch tracks over 25 SEC filing types for ESPR in real-time, scanning EDGAR every 60 seconds. Recent 8-K filings are present; material events disclosures can sometimes precede or accompany capital raises. The DilutionWatch screener shows real-time score changes for ESPR alongside comparable medium-risk stocks. Not financial advice — this analysis is for informational purposes only.

Warrants Explained →